In addition, immunohistochemical data indicates that, at least in part, FAM3B promotes tumorigenicity in these cells by the upregulation of Bcl-2 and downregulation of Bax, with a high correlation between tumor growth and FAM3B/Bcl-2 gene expression. The gene discussed is BCL2; the disease is neoplasm.